Hamit Yasar Ellidag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hamit Yasar Ellidag has a total of 136 co-authors. Here are the top co-authors by number of shared publications:
Esin Eren
13 shared publicationsNecat Yilmaz
7 shared publications- Arif Aslaner
Department of General Surgery, Antalya Education and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey
6 shared publications Ozgur Aydin
Biochemistry Laboratory, Maternity and Children's Hospital, Batman, Turkey
6 shared publications- Uğur Doğan
University of Health Sciences Antalya Training and Research Hospital
5 shared publications Necat Yılmaz
Varlik Mahallesi Kazim Karabekir Caddesi Soguksu
4 shared publications
Latest Publications
- 16 April 2026
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 27 (2) , 276-286
KLİNİK BİYOKİMYADA MOLEKÜLER TANI: SIVI BİYOPSİ
İster tek hücreli, ister çok hücreli olsun, canlılığın en temel dürtüsü varlığını sürdürmek ve hayatta kalmaktır. Bu durum kanser hücreleri içinde geçerlidir. İnsanoğlunun kanserle amansız savaşı devam etmektedir. Bu savaş sırasında düşmanın konumunu ve gücünü tespit etmek temel stratejidir. Bu amaçla günümüzde doku biyopsisi tümör teşhisi için altın standart olmaya devam etmektedir. Bununla birlikte, sıvı biyopsi, tümör hücrelerinden salgılanan dolaşımdaki serbest DNA (cell-free tumor DNA : cftDNA), RNA (circulating cell-free RNA : cfRNA), mikrovezikül (ekzosomlar, ekstrasellüler veziküller :EVs), dolaşımdaki tümör hücreleri (circulating tumor cells (CTCs) ve tümör etkileşimli trombositlerin (tumor-educated platelets (TEPs) tespiti için başta kan, tükrük, idrar gibi vücut salgılarına odaklanan yöntemlerdir. Kanser tanısında sıvı biyopsi, hastalığın erken evrede belirlenmesi, tedavi yanıtının izlenmesi ve tümör genetiğindeki değişikliklerin takip edilmesi açısından büyük önem taşır. Yeni nesil dizileme (NGS), kantitatif polimeraz zincir reaksiyonu (qPCR) ve dijital damlacık PCR (ddPCR) gibi ileri teknolojiler sayesinde sıvı biyopsiden elde edilen verilerin duyarlılığı ve özgüllüğü artırılmaktadır. Kanser dışında sıvı biyopsi, nörodejeneratif hastalıklar, kardiyovasküler hastalıklar, enfeksiyonlar ve genetik bozuklukların teşhisinde de kullanılmaktadır. Kardiyovasküler hastalıklarda ise dolaşımdaki mikroRNA profilleri, hastalığın progresyonu hakkında önemli bilgiler sunmaktadır. Bununla birlikte, sıvı biyopsinin klinik uygulamalara tam anlamıyla entegre edilebilmesi için bazı zorluklar mevcuttur. Bu zorluklar arasında yöntemlerin standardizasyonunun sağlanması, biyobelirteçlerin duyarlılığının artırılması ve klinik doğrulama süreçlerinin tamamlanması bulunmaktadır. Sıvı biyopsiden elde edilen verilerin yorumlanması ve klinik pratiğe aktarılması için ileri biyoinformatik analiz yöntemlerinin geliştirilmesi gerekmektedir. Gelecekte sıvı biyopsi, kanser başta olmak üzere birçok hastalığın yönetiminde standart bir tanı yöntemi haline gelebilir. Özellikle yapay zeka ve makine öğrenmesi tabanlı veri analiz yöntemleri ile sıvı biyopsiden elde edilen bilgilerin daha hassas şekilde değerlendirilmesi mümkün olacaktır. Bu derlemede, şu an oldukça güncel olan sıvı biyopsi yöntemlerinin temel prensipleri, avantajları, sınırlamaları ve klinik uygulama alanları ele alınacaktır.
- 16 April 2026
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 27 (2) , 276-286
KLİNİK BİYOKİMYADA MOLEKÜLER TANI: SIVI BİYOPSİ
İster tek hücreli, ister çok hücreli olsun, canlılığın en temel dürtüsü varlığını sürdürmek ve hayatta kalmaktır. Bu durum kanser hücreleri içinde geçerlidir. İnsanoğlunun kanserle amansız savaşı devam etmektedir. Bu savaş sırasında düşmanın konumunu ve gücünü tespit etmek temel stratejidir. Bu amaçla günümüzde doku biyopsisi tümör teşhisi için altın standart olmaya devam etmektedir. Bununla birlikte, sıvı biyopsi, tümör hücrelerinden salgılanan dolaşımdaki serbest DNA (cell-free tumor DNA : cftDNA), RNA (circulating cell-free RNA : cfRNA), mikrovezikül (ekzosomlar, ekstrasellüler veziküller :EVs), dolaşımdaki tümör hücreleri (circulating tumor cells (CTCs) ve tümör etkileşimli trombositlerin (tumor-educated platelets (TEPs) tespiti için başta kan, tükrük, idrar gibi vücut salgılarına odaklanan yöntemlerdir. Kanser tanısında sıvı biyopsi, hastalığın erken evrede belirlenmesi, tedavi yanıtının izlenmesi ve tümör genetiğindeki değişikliklerin takip edilmesi açısından büyük önem taşır. Yeni nesil dizileme (NGS), kantitatif polimeraz zincir reaksiyonu (qPCR) ve dijital damlacık PCR (ddPCR) gibi ileri teknolojiler sayesinde sıvı biyopsiden elde edilen verilerin duyarlılığı ve özgüllüğü artırılmaktadır. Kanser dışında sıvı biyopsi, nörodejeneratif hastalıklar, kardiyovasküler hastalıklar, enfeksiyonlar ve genetik bozuklukların teşhisinde de kullanılmaktadır. Kardiyovasküler hastalıklarda ise dolaşımdaki mikroRNA profilleri, hastalığın progresyonu hakkında önemli bilgiler sunmaktadır. Bununla birlikte, sıvı biyopsinin klinik uygulamalara tam anlamıyla entegre edilebilmesi için bazı zorluklar mevcuttur. Bu zorluklar arasında yöntemlerin standardizasyonunun sağlanması, biyobelirteçlerin duyarlılığının artırılması ve klinik doğrulama süreçlerinin tamamlanması bulunmaktadır. Sıvı biyopsiden elde edilen verilerin yorumlanması ve klinik pratiğe aktarılması için ileri biyoinformatik analiz yöntemlerinin geliştirilmesi gerekmektedir. Gelecekte sıvı biyopsi, kanser başta olmak üzere birçok hastalığın yönetiminde standart bir tanı yöntemi haline gelebilir. Özellikle yapay zeka ve makine öğrenmesi tabanlı veri analiz yöntemleri ile sıvı biyopsiden elde edilen bilgilerin daha hassas şekilde değerlendirilmesi mümkün olacaktır. Bu derlemede, şu an oldukça güncel olan sıvı biyopsi yöntemlerinin temel prensipleri, avantajları, sınırlamaları ve klinik uygulama alanları ele alınacaktır.
- 17 March 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (1) , 6-11
Evaluation of Orexin A and Orexin B Levels after Bariatric Surgery in Patient with Obesity
This study aimed to evaluate the changes in serum Orexin A and B levels following laparoscopic sleeve gastrectomy (LSG) in patients with obesity. Methods: Thirty obese patients undergoing LSG were evaluated at baseline, 3 months, and 6 months postoperatively for Orexin A and B levels and BMI. Results: A significant reduction in BMI was observed at postoperative 3 and 6 months (p < 0.001). Orexin B levels significantly declined at 6 months compared to preoperative and 3-month values (p = 0.002), while changes in Orexin A were not statistically significant. No correlation was found between orexin levels and BMI. Conclusions: Postoperative reductions in Orexin B may reflect a role in appetite regulation following bariatric surgery. These findings support further investigation into orexin-targeted therapies in obesity management. Methods: Preoperative, postoperative 3rd, and 6th-month venous blood samples were collected from 30 obese patients diagnosed with obesity and undergoing LSG to measure Orexin A and B levels. The obtained values and body maSD indexes (BMI) calculated at the same time intervals were compared. This study was approved by the Clinical Research Ethics Committee of the University of Health Sciences Antalya Training and Research Hospital (Approval Date: August 5, 2021; Approval No: 11/10) and was conducted in accordance with the Declaration of Helsinki. Conclusions: Previous experimental studies have shown that Orexin peptides are activated in the fasting state and play an active role in obesity by increasing food intake. In this study, we found that Orexin B levels were significantly reduced in patients who experienced weight loss. We believe that monitoring Orexin levels can be beneficial in the treatment of obesity, and inhibiting its activity at the hypothalamic level can contribute to the treatment by reducing food intake. Conducting new studies with a larger number of patients and longer follow-up periods will lead to radical and effective changes in the treatment of obesity.
- 17 March 2026
- Published by Cukurova Anestezi ve Cerrahi Bilimler Dergisi in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
- Vol. 9 (1) , 6-11
Evaluation of Orexin A and Orexin B Levels after Bariatric Surgery in Patient with Obesity
This study aimed to evaluate the changes in serum Orexin A and B levels following laparoscopic sleeve gastrectomy (LSG) in patients with obesity. Methods: Thirty obese patients undergoing LSG were evaluated at baseline, 3 months, and 6 months postoperatively for Orexin A and B levels and BMI. Results: A significant reduction in BMI was observed at postoperative 3 and 6 months (p < 0.001). Orexin B levels significantly declined at 6 months compared to preoperative and 3-month values (p = 0.002), while changes in Orexin A were not statistically significant. No correlation was found between orexin levels and BMI. Conclusions: Postoperative reductions in Orexin B may reflect a role in appetite regulation following bariatric surgery. These findings support further investigation into orexin-targeted therapies in obesity management. Methods: Preoperative, postoperative 3rd, and 6th-month venous blood samples were collected from 30 obese patients diagnosed with obesity and undergoing LSG to measure Orexin A and B levels. The obtained values and body maSD indexes (BMI) calculated at the same time intervals were compared. This study was approved by the Clinical Research Ethics Committee of the University of Health Sciences Antalya Training and Research Hospital (Approval Date: August 5, 2021; Approval No: 11/10) and was conducted in accordance with the Declaration of Helsinki. Conclusions: Previous experimental studies have shown that Orexin peptides are activated in the fasting state and play an active role in obesity by increasing food intake. In this study, we found that Orexin B levels were significantly reduced in patients who experienced weight loss. We believe that monitoring Orexin levels can be beneficial in the treatment of obesity, and inhibiting its activity at the hypothalamic level can contribute to the treatment by reducing food intake. Conducting new studies with a larger number of patients and longer follow-up periods will lead to radical and effective changes in the treatment of obesity.
- Open Access
- 6 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (6) , e47620
Altered vaspin levels in hypothyroid patients: A potential marker of metabolic dysregulation
This study investigates alterations in vaspin levels in hypothyroid patients and their role in metabolic processes and thyroid function. By analyzing the correlation between vaspin levels and hypothyroidism, the research aims to elucidate metabolic dysregulation in thyroid disorders and the potential link between thyroid hormones and adipose tissue function. This study included patients with hypothyroidism and healthy controls. Comprehensive data and laboratory findings were collected from hospital electronic health records. Vaspin levels were analyzed to explore the association with hypothyroidism. The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) was also calculated. The study included 90 participants: 54 in the hypothyroid group and 36 in the control group. The hypothyroid group had a significantly higher age (49.04 ± 11.89 vs 43.53 ± 9.76 years, P = .019). Thyroid function tests showed substantially higher thyroid-stimulating hormone and lower fT4 levels in the hypothyroid group, confirming impaired thyroid function. Notably, vaspin levels were significantly lower in the hypothyroid group than in the control group (2.24 ng/mL vs 3.51 ng/mL, P = .008). This finding suggests that hypothyroidism may lead to altered adipokine regulation, potentially contributing to metabolic dysfunction. No significant differences were observed between the groups for lipid profile, glucose metabolism, insulin resistance (HOMA-IR), hematological, or liver enzymes. This study found lower vaspin levels in hypothyroid patients, which may be related to metabolic dysregulation. Vaspin could serve as a therapeutic target for addressing metabolic disturbances in hypothyroidism. Further research is needed to explore its clinical implications.
- 6 February 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (6) , e47620
Open AccessAltered vaspin levels in hypothyroid patients: A potential marker of metabolic dysregulation
This study investigates alterations in vaspin levels in hypothyroid patients and their role in metabolic processes and thyroid function. By analyzing the correlation between vaspin levels and hypothyroidism, the research aims to elucidate metabolic dysregulation in thyroid disorders and the potential link between thyroid hormones and adipose tissue function. This study included patients with hypothyroidism and healthy controls. Comprehensive data and laboratory findings were collected from hospital electronic health records. Vaspin levels were analyzed to explore the association with hypothyroidism. The Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) was also calculated. The study included 90 participants: 54 in the hypothyroid group and 36 in the control group. The hypothyroid group had a significantly higher age (49.04 ± 11.89 vs 43.53 ± 9.76 years, P = .019). Thyroid function tests showed substantially higher thyroid-stimulating hormone and lower fT4 levels in the hypothyroid group, confirming impaired thyroid function. Notably, vaspin levels were significantly lower in the hypothyroid group than in the control group (2.24 ng/mL vs 3.51 ng/mL, P = .008). This finding suggests that hypothyroidism may lead to altered adipokine regulation, potentially contributing to metabolic dysfunction. No significant differences were observed between the groups for lipid profile, glucose metabolism, insulin resistance (HOMA-IR), hematological, or liver enzymes. This study found lower vaspin levels in hypothyroid patients, which may be related to metabolic dysregulation. Vaspin could serve as a therapeutic target for addressing metabolic disturbances in hypothyroidism. Further research is needed to explore its clinical implications.
- Open Access
- 8 January 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Serum xenopsin-related peptide-1 levels in pregnant women with hyperemesis gravidarum; a cross-sectional study
To investigate serum xenopsin-related peptide (XRP) -1 levels in women with hyperemesis gravidarum (HEG) from the onset of pregnancy until the end of week
- 8 January 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessSerum xenopsin-related peptide-1 levels in pregnant women with hyperemesis gravidarum; a cross-sectional study
To investigate serum xenopsin-related peptide (XRP) -1 levels in women with hyperemesis gravidarum (HEG) from the onset of pregnancy until the end of week
- 18 July 2025
- Published by Taylor & Francis in Biotechnic & Histochemistry
- Vol. 100 (6) , 360-370
Serum perilipin-2 levels in a rat model of liver ischemia-reperfusion injury
Liver ischemia and ischemia/reperfusion (I/R) injury are common in hepatic resection, trauma surgery, and transplantation and contribute to postoperative morbidity and mortality. This study aimed to investigate the relationship between early histopathological changes due to liver I/R injury and serum levels of perilipin-2 (Plin2) and other oxidative stress biomarkers. Fifty female Wistar albino rats were divided into five groups: Group 1 (control), Group 2 (ischemia for 30 minutes), and Groups 3-5 (ischemia followed by 1, 2, or 3 hours of reperfusion). Intracardiac and arterial blood samples were collected for biochemical analysis, while liver tissue samples were used for histopathological examination. Serum levels of Plin2, ischemia-modified albumin (IMA), total antioxidant status (TAS), and total oxidant status (TOS) were measured. Plin2 levels were significantly lower in the ischemia group compared to others (p < 0.01). The control group had significantly lower IMA, TOS, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels (p < 0.01) and lower TAS levels (p < 0.05). Rats with Grade 1 liver injury showed significantly lower Plin2 (p < 0.01) and higher IMA levels (p < 0.05). Reduced serum Plin2 following ischemia suggests its potential as a biomarker for acute liver injury. Further studies are needed to clarify its role across different reperfusion durations.
- 18 July 2025
- Published by Taylor & Francis in Biotechnic & Histochemistry
- Vol. 100 (6) , 360-370
Serum perilipin-2 levels in a rat model of liver ischemia-reperfusion injury
Liver ischemia and ischemia/reperfusion (I/R) injury are common in hepatic resection, trauma surgery, and transplantation and contribute to postoperative morbidity and mortality. This study aimed to investigate the relationship between early histopathological changes due to liver I/R injury and serum levels of perilipin-2 (Plin2) and other oxidative stress biomarkers. Fifty female Wistar albino rats were divided into five groups: Group 1 (control), Group 2 (ischemia for 30 minutes), and Groups 3-5 (ischemia followed by 1, 2, or 3 hours of reperfusion). Intracardiac and arterial blood samples were collected for biochemical analysis, while liver tissue samples were used for histopathological examination. Serum levels of Plin2, ischemia-modified albumin (IMA), total antioxidant status (TAS), and total oxidant status (TOS) were measured. Plin2 levels were significantly lower in the ischemia group compared to others (p < 0.01). The control group had significantly lower IMA, TOS, aspartate aminotransferase (AST), and alanine aminotransferase (ALT) levels (p < 0.01) and lower TAS levels (p < 0.05). Rats with Grade 1 liver injury showed significantly lower Plin2 (p < 0.01) and higher IMA levels (p < 0.05). Reduced serum Plin2 following ischemia suggests its potential as a biomarker for acute liver injury. Further studies are needed to clarify its role across different reperfusion durations.
- Open Access
- 30 June 2025
- Published by Universidad del Valle in Colombia Medica
- Vol. 56 (2) , e2016690
Serum Interleukin-36γ Levels in Children with Allergic Rhinitis
Objectives: This study aimed to investigate whether serum Interleukin 36 gamma (IL-36γ) levels in pediatric allergic rhinitis patients correlate with disease severity (mild, moderate, severe) and duration (intermittent, persistent). Additionally, we assessed the potential of IL-36γ as a biomarker and its role in disease pathogenesis to inform future treatment strategies. Methods: In this cross-sectional observational study, pediatric allergic rhinitis patients from outpatient clinics were compared with healthy controls. Serum IL-36γ levels were measured from blood samples and analyzed across subgroups based on disease severity and duration. Results: Fifty patients with allergic rhinitis and forty controls were included. IL-36γ levels were higher in the patient group with borderline significance (p= 0.050). Female patients had significantly higher IL-36γ levels than male controls (p= 0.044). Conclusions:This is the first study to evaluate IL-36γ levels in pediatric allergic rhinitis. Although the difference between groups showed borderline significance, larger studies may confirm these findings. The observed gender-related difference suggests IL-36γ could be a potential biomarker. Additionally, a significant negative correlation with total IgE and a nonsignificant negative correlation with eosinophil counts were noted.
- 30 June 2025
- Published by Universidad del Valle in Colombia Medica
- Vol. 56 (2) , e2016690
Open AccessSerum Interleukin-36γ Levels in Children with Allergic Rhinitis
Objectives: This study aimed to investigate whether serum Interleukin 36 gamma (IL-36γ) levels in pediatric allergic rhinitis patients correlate with disease severity (mild, moderate, severe) and duration (intermittent, persistent). Additionally, we assessed the potential of IL-36γ as a biomarker and its role in disease pathogenesis to inform future treatment strategies. Methods: In this cross-sectional observational study, pediatric allergic rhinitis patients from outpatient clinics were compared with healthy controls. Serum IL-36γ levels were measured from blood samples and analyzed across subgroups based on disease severity and duration. Results: Fifty patients with allergic rhinitis and forty controls were included. IL-36γ levels were higher in the patient group with borderline significance (p= 0.050). Female patients had significantly higher IL-36γ levels than male controls (p= 0.044). Conclusions:This is the first study to evaluate IL-36γ levels in pediatric allergic rhinitis. Although the difference between groups showed borderline significance, larger studies may confirm these findings. The observed gender-related difference suggests IL-36γ could be a potential biomarker. Additionally, a significant negative correlation with total IgE and a nonsignificant negative correlation with eosinophil counts were noted.
- 27 June 2025
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 51 (1) , 1-14
Determination of SCUBE-1, SCUBE-2, caveolin-1, and ischemia biomarker levels in rats following renal ischemia-reperfusion
Purpose To investigate the histopathological findings and serum levels of ischemia and oxidative stress biomarkers in a rat model of renal ischemia-reperfusion injury. Methods Fifty-one female Wistar rats were randomly allocated into six groups: ischemia/third day, ischemia/first week, ischemia/second week, and corresponding control groups for each ischemia group. Each ischemia group had 10 rats, and each control group had seven. Ischemia was induced by clamping the left renal hilum for 45 min, followed by reperfusion. Relaparotomy was performed at designated time points, and blood and kidney samples were collected. Control groups underwent laparotomy without ischemia. Serum levels of signal peptide-complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor-like domain-containing protein 1 and 2 (SCUBE-1/2), caveolin-1 (Cav-1), albumin, ischemia-modified albumin (IMA), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), IMA/albumin ratio (IMAR), creatinine, and blood urea nitrogen were analyzed, and histopathological examinations were undertaken. Results In the ischemia groups, serum levels of SCUBE-1, IMA, TAS, TOS, creatinine, IMAR, and OSI statistically significantly differed from those in the control groups. Serum Cav-1 levels showed a statistically significant difference between the third-day and first-week groups, whereas no statistically significant difference was observed between the ischemia and control groups in the second-week cohort. Conclusion Significant differences in ischemia and oxidative stress biomarkers, including SCUBE-1 and Cav-1, were observed. SCUBE-1 and Cav-1 may serve as potential biomarkers for assessing kidney injury, function, and recovery.
- 27 June 2025
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 51 (1) , 1-14
Determination of SCUBE-1, SCUBE-2, caveolin-1, and ischemia biomarker levels in rats following renal ischemia-reperfusion
Purpose To investigate the histopathological findings and serum levels of ischemia and oxidative stress biomarkers in a rat model of renal ischemia-reperfusion injury. Methods Fifty-one female Wistar rats were randomly allocated into six groups: ischemia/third day, ischemia/first week, ischemia/second week, and corresponding control groups for each ischemia group. Each ischemia group had 10 rats, and each control group had seven. Ischemia was induced by clamping the left renal hilum for 45 min, followed by reperfusion. Relaparotomy was performed at designated time points, and blood and kidney samples were collected. Control groups underwent laparotomy without ischemia. Serum levels of signal peptide-complement C1r/C1s, Uegf, and Bmp1-epidermal growth factor-like domain-containing protein 1 and 2 (SCUBE-1/2), caveolin-1 (Cav-1), albumin, ischemia-modified albumin (IMA), total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI), IMA/albumin ratio (IMAR), creatinine, and blood urea nitrogen were analyzed, and histopathological examinations were undertaken. Results In the ischemia groups, serum levels of SCUBE-1, IMA, TAS, TOS, creatinine, IMAR, and OSI statistically significantly differed from those in the control groups. Serum Cav-1 levels showed a statistically significant difference between the third-day and first-week groups, whereas no statistically significant difference was observed between the ischemia and control groups in the second-week cohort. Conclusion Significant differences in ischemia and oxidative stress biomarkers, including SCUBE-1 and Cav-1, were observed. SCUBE-1 and Cav-1 may serve as potential biomarkers for assessing kidney injury, function, and recovery.
- 18 February 2025
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 51 (1) , 1-11
The role of serum vaspin level in the early diagnosis of mesenteric ischemia induced in experimental animal model
Purpose Acute mesenteric ischaemia (AMI) is one of the abdominal surgical emergencies with high mortality and morbidity and early diagnosis and treatment are of vital importance. We aimed to evaluate the usefulness of serum vaspin level as a potential biomarker for early diagnosis of AMI in an experimental animal model. Materials and methods Sixty female Wistar-Albino rats were divided into 6 groups. Ischaemia groups (1, 3, 5) underwent SMA dissection and ligation, while control groups (2, 4, 6) did not. Blood and intestinal tissue samples were collected at 30 min, 2 h, and 6 h. Vaspin (ng/ml), TAS (Total antioxidant capacity, μmol Trolox equiv./L), TOS (Total oxidant capacity, μmol H2O2 equiv./L), ALT (Alanine Aminotransferase, U/L), AST (Aspartate Aminotransferase, U/L) and OSI (TOS/TAS) ratio of these biochemical values were studied. Results Vaspin levels were compared at 30 min, 2 h, and 6 h in ischaemia and control groups. No significant difference was found at 30 min and 2 h (p > 0.05), but a significant increase was observed at 6 h (p < 0.05). There was a statistically significant difference between the Vaspin (ng/ml) measurements of the ischaemia groups at three different times (p < 0.05). The highest Vaspin (ng/ml) value was obtained at the 6th hour and the lowest at the 30th minute. Conclusion In our study, a statistically significant increase in vaspin levels was detected with increasing ischaemia duration and necrosis. These findings suggest that vaspin may be a potential biomarker in the early diagnosis of AMI.
- 18 February 2025
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 51 (1) , 1-11
The role of serum vaspin level in the early diagnosis of mesenteric ischemia induced in experimental animal model
Purpose Acute mesenteric ischaemia (AMI) is one of the abdominal surgical emergencies with high mortality and morbidity and early diagnosis and treatment are of vital importance. We aimed to evaluate the usefulness of serum vaspin level as a potential biomarker for early diagnosis of AMI in an experimental animal model. Materials and methods Sixty female Wistar-Albino rats were divided into 6 groups. Ischaemia groups (1, 3, 5) underwent SMA dissection and ligation, while control groups (2, 4, 6) did not. Blood and intestinal tissue samples were collected at 30 min, 2 h, and 6 h. Vaspin (ng/ml), TAS (Total antioxidant capacity, μmol Trolox equiv./L), TOS (Total oxidant capacity, μmol H2O2 equiv./L), ALT (Alanine Aminotransferase, U/L), AST (Aspartate Aminotransferase, U/L) and OSI (TOS/TAS) ratio of these biochemical values were studied. Results Vaspin levels were compared at 30 min, 2 h, and 6 h in ischaemia and control groups. No significant difference was found at 30 min and 2 h (p > 0.05), but a significant increase was observed at 6 h (p < 0.05). There was a statistically significant difference between the Vaspin (ng/ml) measurements of the ischaemia groups at three different times (p < 0.05). The highest Vaspin (ng/ml) value was obtained at the 6th hour and the lowest at the 30th minute. Conclusion In our study, a statistically significant increase in vaspin levels was detected with increasing ischaemia duration and necrosis. These findings suggest that vaspin may be a potential biomarker in the early diagnosis of AMI.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 40, e404225
Naringin in cholestatic liver ischemia-reperfusion injury
Purpose: To evaluate the potential protective effects of naringin on liver by oxidative parameters and signal peptide-CUB-EGF-like domain-containing protein (SCUBE)-1 and 2 in an experimental cholestatic liver ischemia reperfusion (IR) model.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Acta Cirurgica Brasileira
- Vol. 40, e404225
Open AccessNaringin in cholestatic liver ischemia-reperfusion injury
Purpose: To evaluate the potential protective effects of naringin on liver by oxidative parameters and signal peptide-CUB-EGF-like domain-containing protein (SCUBE)-1 and 2 in an experimental cholestatic liver ischemia reperfusion (IR) model.
- 1 September 2024
- Published by Pleiades Publishing Ltd in Neurochemical Journal
- Vol. 18 (3) , 515-520
S100B, GFAP and NSE: The Role of Neuro Biomarkers for Early Predictors of Cerebral Vaso-Occlusive Manifestations of Sickle Cell Disease
Hemoglobinopathies are commonly occurring genetic disorders worldwide. The aim of this study is to determine the biochemical predictors of cerebrovascular complications in pediatric patients with sickle cell anemia. We investigated the relationship between levels of neurological damage markers, such as Serum S100 calcium-binding protein B (S100B), Glial Fibrillary Acidic Protein (GFAP), and Neuron-Specific Enolase (NSE), and radiological findings in these patients. A total of 72 SCD patients and 30 healthy children were included in the study. Clinical and laboratory findings were recorded. Time-averaged maximum mean velocity (TAMMV) values were obtained from transcranial Doppler ultrasonography imaging (TCDI) of the middle cerebral artery. Serum levels of S100B, GFAP, and NSE were measured using the ELISA method both in the SCD group and the control group. Among the patients, 51 had sickle cell anemia (HbSS), 21 had HbSβ0 thalassemia, with 32 (44.4%) being female and 40 (55.6%) male. Their mean age was 12.68 ± 4.56 (ranging from 3 to 24) years old. S100B, GFAP, and NSE serum levels were significantly higher in the SCD group compared to the control group. It was observed that serum levels of S100B, NSE, and GFAP were higher in the group with TAMMV ≥ 170 cm/s. As known, in patients with SCD, the disruption of the blood-brain barrier begins with the occurrence of vaso-occlusive events. Hence, the risk of cerebrovascular events increases. Our study’s indication that serum levels of S100B, GFAP, and NSE could be used in predicting or detecting cerebrovascular events in the early stages is noteworthy.
- 1 September 2024
- Published by Pleiades Publishing Ltd in Neurochemical Journal
- Vol. 18 (3) , 515-520
S100B, GFAP and NSE: The Role of Neuro Biomarkers for Early Predictors of Cerebral Vaso-Occlusive Manifestations of Sickle Cell Disease
Hemoglobinopathies are commonly occurring genetic disorders worldwide. The aim of this study is to determine the biochemical predictors of cerebrovascular complications in pediatric patients with sickle cell anemia. We investigated the relationship between levels of neurological damage markers, such as Serum S100 calcium-binding protein B (S100B), Glial Fibrillary Acidic Protein (GFAP), and Neuron-Specific Enolase (NSE), and radiological findings in these patients. A total of 72 SCD patients and 30 healthy children were included in the study. Clinical and laboratory findings were recorded. Time-averaged maximum mean velocity (TAMMV) values were obtained from transcranial Doppler ultrasonography imaging (TCDI) of the middle cerebral artery. Serum levels of S100B, GFAP, and NSE were measured using the ELISA method both in the SCD group and the control group. Among the patients, 51 had sickle cell anemia (HbSS), 21 had HbSβ0 thalassemia, with 32 (44.4%) being female and 40 (55.6%) male. Their mean age was 12.68 ± 4.56 (ranging from 3 to 24) years old. S100B, GFAP, and NSE serum levels were significantly higher in the SCD group compared to the control group. It was observed that serum levels of S100B, NSE, and GFAP were higher in the group with TAMMV ≥ 170 cm/s. As known, in patients with SCD, the disruption of the blood-brain barrier begins with the occurrence of vaso-occlusive events. Hence, the risk of cerebrovascular events increases. Our study’s indication that serum levels of S100B, GFAP, and NSE could be used in predicting or detecting cerebrovascular events in the early stages is noteworthy.